{
  "meta": {
    "id": "test11",
    "title": "Autoimmune Cholangiopathies",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Which of the following statements is false regarding primary biliary cholangitis?",
      "options": [
        {
          "label": "A",
          "text": "It is an autoimmune disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Primarily involve large intrahepatic ducts",
          "correct": true
        },
        {
          "label": "C",
          "text": "95% of patients show anti-mitochondrial antibody",
          "correct": false
        },
        {
          "label": "D",
          "text": "Elevated levels of serum ALP",
          "correct": false
        }
      ],
      "correct_answer": "B. Primarily involve large intrahepatic ducts",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Primarily involve large intrahepatic ducts Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease characterized by the progressive destruction of the intrahepatic bile ducts. The disease primarily affects the small intrahepatic bile duct s, not the large ones.</p>\n<p><strong>Highyeild:</strong></p><p>Primary biliary cholangiti Chronic autoimmune liver disease Classically seen with other autoimmune conditions: Hashimoto thyroiditis, Rheumatoid arthritis, celiac disease More common in females than males Symptoms: Jaundice, pruritus, osteopenia, portal hypertensio n Histopathology: Lymphocytic infiltrate Destruction of lobular bile ducts (small intrahepatic bile ducts) Ductopenia Florid duct lesions (Granuloma) seen -Diagnosis: Antimitochondrial antibody present Elevated alkaline phosphatase (ALP) Elevated \u03b3-glutamyltransferase (GGT) -Treatment: Ursodeoxycholic acid</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option:A, C, D: All are true</p>\n<p><strong>Table:</strong></p><p>Difference between Primary Biliary Cholangitis and Primary\n     Sclerosing Cholangitis Primary Biliary Cholangitis Primary Sclerosing Cholangitis Incidence Females> Males Middle age Males > Females 20- 40 years of age Site of involvement Intrahepatic Intrahepatic and Extrahepatic Cause of obstruction Granulomatous inflammation destroying bile ducts Fibrosis destroy s bile ducts Microscopy Florid duct lesions (Granuloma?) Concentric onion-skin fibrosis around bile ducts Diagnosis AMA antibody positive MPO-ANCA/ P-ANCA positive The beaded appearance of bile ducts on ERCP Association other autoimmune disorders Ulcerative colitis (Hashimoto\u2019s thyroiditis, S jogren 's )</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "de2f3646",
      "audio": ""
    },
    {
      "text": "Which of the following statement are true regarding primary sclerosing cholangitis:",
      "options": [
        {
          "label": "A",
          "text": "The most common antibody seen is pANCA",
          "correct": false
        },
        {
          "label": "B",
          "text": "It is associated with ulcerative colitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "HPE shows circumferential onion skin fibrosis around the duct",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>All of the above Primary sclerosing cholangitis is an immune mediated cholestatic disease. All the statements given above are true with respect to PSC. Hence, the correct option is D: All of the above.</p>\n<p><strong>Highyeild:</strong></p><p>Primary Sclerosing Cholangitis Sclerosing: as it causes scarring and thickening (sclerosis) of the bile ducts Cholangitis: it means inflammation of the bile ducts. It is an immune-mediated cholestatic liver disease. It is characterised by inflammation and fibrosis of both intrahepatic and extrahepatic bile ducts. It leads to the formation of multimodal bile duct strictures More common in males Histopathology: Shows circumferential onion skin fibrosis around the duct Atrophic duct lumen eventually leading to obliteration by a tombstone scar Diagnosis: MPO-ANCA/ P-ANCA positive The beaded appearance of bile duct s on ERCP Associated with Ulcerative colitis (70% of cases)</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option:A.,B.,C. All are true regarding Primary sclerosing cholangitis.</p>\n<p><strong>Table:</strong></p><p>Difference between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Primary Biliary Cholangitis Primary Sclerosing Cholangitis Incidence Females> Males Middle age Males > Females 20- 40 years of age Site of involvement Intrahepatic Intrahepatic and Extrahepatic Cause of obstruction Granulomatous inflammation destroying bile ducts Fibrosis destroy s bile ducts Microscopy Florid duct lesions (Granuloma?) Concentric onion-skin fibrosis around bile ducts Diagnosis AMA antibody positive MPO-ANCA/ P-ANCA positive The beaded appearance of bile ducts on ERCP Association other autoimmune disorders Ulcerative colitis (Hashimoto\u2019s thyroiditis, S jogren 's )</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e4f16bed",
      "audio": ""
    },
    {
      "text": "A 54-year-old patient presented with jaundice( raised direct bilirubin) and the presence of a pANCA antibody. The liver biopsy is shown below. What is your diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Primary biliary cirrhosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Primary sclerosing cholangitis",
          "correct": true
        },
        {
          "label": "C",
          "text": "Hepatolithiasis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Biliary atresia",
          "correct": false
        }
      ],
      "correct_answer": "B. Primary sclerosing cholangitis",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1689157720957-QTDP123004IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Primary sclerosing cholangitis The given clinical scenario with a histopathological image of liver biopsy showing onion skin fibrosis is suggestive of primary sclerosing cholangitis (PSC)</p>\n<p><strong>Highyeild:</strong></p><p>Primary Sclerosing Cholangitis Sclerosing: as it causes scarring and thickening (sclerosis) of the bile ducts Cholangitis: means inflammation of the bile ducts. It is an immune-mediated cholestatic liver disease. It is characterised by inflammation and fibrosis of both intrahepatic and extrahepatic bile ducts. It leads to the formation of multimodal bile duct strictures More common in males Histopathology: Shows circumferential onion skin fibrosis around the duct Atrophic duct lumen eventually leading to obliteration by a tombstone scar Diagnosis: MPO-ANCA/ P-ANCA positive The beaded appearance of bile duct s on ERCP Associated with Ulcerative colitis (70% of cases)</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Primary biliary cirrhosis: It typically presents with elevated levels of anti-mitochondrial antibodies, chronic cholestasis, and a characteristic histopathological finding of granulomatous destruction of small intrahepatic bile ducts. Option: C. Hepatolithiasis: It is a condition in which stones are present in the intrahepatic bile ducts. Option: D. Biliary atresia: It is a rare condition in which the bile ducts inside or outside the liver are damaged or absent, leading to bile flow obstruction and subsequent liver damage. It typically presents in infants with jaundice and acholic stools.</p>\n<p><strong>Table:</strong></p><p>Difference between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Primary Biliary Cholangitis Primary Sclerosing Cholangitis Incidence Females> Males Middle age Males > Females 20- 40 years of age Site of involvement Intrahepatic Intrahepatic and Extrahepatic Cause of obstruction Granulomatous inflammation destroying bile ducts Fibrosis destroy s bile ducts Microscopy Florid duct lesions (Granuloma?) Concentric onion-skin fibrosis around bile ducts Diagnosis AMA antibody positive MPO-ANCA/ P-ANCA positive The beaded appearance of bile ducts on ERCP Association other autoimmune disorders Ulcerative colitis (Hashimoto\u2019s thyroiditis, S jogren 's )</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "649dd947",
      "audio": ""
    },
    {
      "text": "All of the mentioned antibodies are seen in type 1 autoimmune hepatitis except",
      "options": [
        {
          "label": "A",
          "text": "Anti-smooth muscle actin (SMA)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Antinuclear antibody",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anti-mitochondrial antibody",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anti LKM 1",
          "correct": true
        }
      ],
      "correct_answer": "D. Anti LKM 1",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Anti LKM 1 Anti-LKM 1 antibody is not seen in Autoimmune hepatitis type 1 . It Is seen in Type 2 autoimmune hepatitis.</p>\n<p><strong>Highyeild:</strong></p><p>Autoimmune hepatitis Autoimmune hepatitis is a chronic autoimmune liver disease that is characterized by inflammation and damage to liver cells. It leads to cirrhosis and liver failure Associated with HLA-B1, HLA-B8, HLA-DR3, HLA-DR4 Histopathology: Extensive interface hepatitis (inflammation at the interface between hepatocytes and the portal tract), Plasma cell infiltrates , Presence of hepatic rosettes (clusters of hepatocytes that surround a central bile duct)</p>\n<p><strong>Extraedge:</strong></p><p>TYPE 1 AIH TYPE 2 AIH Antibodies Anti-SMA, ANA, pANCA, and antibodies anti-SLA Anti LKM1, anti-liver cytoskeleton 1 Incidence \u25cf       Bimodal: peaks at 10-20 years and 45-70 years \u25cf       78% females \u25cf       2-14 years \u25cf       89% females IgG Pronouncedly increased Moderate increase IgA Absent Occasional Association HLA B8, DR3, DR4 HLA B14, DR3</p>\n<p><strong>Table:</strong></p><p>Antibodies in hepatitis Disease Antibodies Autoimmune hepatitis type 1 ANA, ASMA, pANCA, anti-AMA, anti-SLA Autoimmune hepatitis type 2 Anti-liver cytosol 1, Anti-LKM1 Drug - induced hepatitis Anti-LKM 2 Chronic hepatitis C Anti-LKM 1 Chronic hepatitis D Anti-LKM 3</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "307df53e",
      "audio": ""
    },
    {
      "text": "Which of the following are histological features of autoimmune hepatitis?",
      "options": [
        {
          "label": "A",
          "text": "Extensive interface hepatitis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Plasma cell infiltrate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hepatocyte rosette",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>All of the above All of the statements given above are true with respect to histological findings of autoimmune hepatitis. Hence, the correct option is D. All of the above.</p>\n<p><strong>Highyeild:</strong></p><p>Autoimmune hepatitis Autoimmune hepatitis is a chronic autoimmune liver disease that is characterized by inflammation and damage to liver cells. It leads to cirrhosis and liver failure Associated with HLA-B1, HLA-B8, HLA-DR3, HLA-DR4 Histopathology: Extensive interface hepatitis (inflammation at the interface between hepatocytes and the portal tract), Plasma cell infiltrates , Presence of hepatic rosettes (clusters of hepatocytes that surround a central bile duct)</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Extensive interface hepatitis: Interface hepatitis refers to the inflammation at the interface between the hepatocytes (liver cells) and the portal tracts. Option: B. Plasma cell infiltrate: Autoimmune hepatitis is known to exhibit a significant infiltration of plasma cells.These plasma cells are involved in the production of antibodies that target liver cells, contributing to the autoimmune response. Option: C. Hepatocyte rosette: These are a specific histological feature observed in autoimmune hepatitis. They are characterized by hepatocytes forming concentric circles around the central vein, resembling a rosette-like pattern. This pattern is thought to be a result of the immune-mediated destruction of hepatocytes.</p>\n<p><strong>Extraedge:</strong></p><p>TYPE 1 AIH TYPE 2 AIH Antibodies Anti-SMA, ANA, pANCA, anti-AMA, anti-SLA Anti LKM1, anti-liver cytoskeleton 1 Incidence \u25cf       Bimodal: peaks at 10-20 years and 45-70 years \u25cf       78% females \u25cf       2-14 years \u25cf       89% females IgG Pronouncedly increased Moderate increase IgA Absent Occasional Association HLA B8,DR3,DR4 HLA B14, DR3</p>\n<p><strong>Table:</strong></p><p>Antibodies\n     in hepatitis Disease Antibodies Autoimmune hepatitis type 1 ANA, ASMA, pANCA, anti-AMA, anti-SLA Autoimmune hepatitis type 2 Anti-liver cytosol 1, Anti-LKM1 Drug - induced\n  hepatitis Anti-LKM 2 Chronic hepatitis C Anti-LKM 1 Chronic hepatitis D Anti-LKM 3</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ccf8188a",
      "audio": ""
    }
  ]
}